lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed and are posted here as part of a 12-month trial. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Clinical Characteristics of 60 COVID-19-Infected Patients with or Without Renal Injury In Hangzhou, China

18 Pages Posted: 20 Feb 2020

See all articles by Zhijun Xie

Zhijun Xie

Zhejiang Chinese Medical University

Jianfeng Bao

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Zhaobin Cai

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Shourong Liu

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Haiping Chen

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Jianjiang Qi

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Jianhua Yu

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Jianchun Guo

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Liangbin Miu

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Zhaoyi Li

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Jing Sun

Zhejiang Chinese Medical University

Hui Yang

Zhejiang Chinese Medical University

Lin Huang

Zhejiang Chinese Medical University

Yujun Tang

Zhejiang Chinese Medical University

Zhiyu Li

Zhejiang Chinese Medical University

Yi Zhang

Zhejiang Chinese Medical University

Jinsong Huang

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Chengping Wen

Zhejiang Chinese Medical University

More...

Abstract

Background: Up to now, COVID-19 has infected more than 60 thousand of people in China and is gradually spread globally. The disease was named as Novel coronavirus pneumonia (NCP) on February 8th. We analyzed data on 60 confirmed cases in Hangzhou to determine the clinical characteristics of NCP with or without renal injury.

Methods: In this cross-sectional, descriptive study, we collected clinical information on demographic characteristics, pulmonary high resolution computerized tomography (HRCT) imaging and other clinical indicators of NCP cases. Urine protein(Upro) was used to divided patients into the Upro positive group (Upro+ group) and the negative Upro group(Upro- group). Then difference of clinical indexes between the two groups and relationship between Upro and clinical indexes were analyzed.

Findings: Among the 60 patients, Upro positive rate was 51.67%, and urine protein and urine erythrocyte co-positive rate was 11.67%. The level of blood lymphocyte, serum Age, married, BMI, history of hypertension, ALT, AST, Glb, Scr, LDH, lymphocyte, CRP and moderate pulmonary HRCT imaging of Upro+ group were remarkably severe than those of Upro- group (P < 0.05). Abnormal rates of AST and CRP were significantly higher in Upro+ group. The results of binary regression analysis showed that Scr (OR=1.1;), AST (OR=1.199), age (OR=1.1) and grade of pulmonary HRCT imaging (OR=0.315) were homodirectional impact factors and blood lymphocyte(OR=0.222) was the reverse impact factor of urine protein positive.

Interpretation: High rate of Upro positive was detected in NCP patients, The degree of pulmonary lesion is positively related with level of Upro. Moreover, age, AST and lymphopenia were homodirectional impact factors with Upro. This study reminded us to pay more attention to the protective measures for lung, kidney and heart in the early stage of clinical treatment, and the mechanisms of how COVID-19 induced renal injury need to be future studied.

Funding Statement: Zhejiang Natural Science Foundation Committee.

Declaration of Interests: All authors declare no competing interests.

Ethics Approval Statement: This study was approved by the Ethics Commission of Hangzhou Xixi Hospital affiliated to Zhejiang Chinese Medical University (2020- KLS-15).

Keywords: cross-sectional, descriptive study; Clinical Characteristics; COVID-19; renal Injury

Suggested Citation

Xie, Zhijun and Bao, Jianfeng and Cai, Zhaobin and Liu, Shourong and Chen, Haiping and Qi, Jianjiang and Yu, Jianhua and Guo, Jianchun and Miu, Liangbin and Li, Zhaoyi and Sun, Jing and Yang, Hui and Huang, Lin and Tang, Yujun and Li, Zhiyu and Zhang, Yi and Huang, Jinsong and Wen, Chengping, Clinical Characteristics of 60 COVID-19-Infected Patients with or Without Renal Injury In Hangzhou, China (February 19, 2020). Available at SSRN: https://ssrn.com/abstract=3541126 or http://dx.doi.org/10.2139/ssrn.3541126

Zhijun Xie

Zhejiang Chinese Medical University

Hangzhou, Zhejiang
China

Jianfeng Bao

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Hangzhou, 310023
China

Zhaobin Cai

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Hangzhou, 310023
China

Shourong Liu

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Hangzhou, 310023
China

Haiping Chen

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Hangzhou, 310023
China

Jianjiang Qi

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Hangzhou, 310023
China

Jianhua Yu

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Hangzhou, 310023
China

Jianchun Guo

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Hangzhou, 310023
China

Liangbin Miu

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Hangzhou, 310023
China

Zhaoyi Li

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Hangzhou, 310023
China

Jing Sun

Zhejiang Chinese Medical University

Hangzhou, Zhejiang
China

Hui Yang

Zhejiang Chinese Medical University

Hangzhou, Zhejiang
China

Lin Huang

Zhejiang Chinese Medical University

Hangzhou, Zhejiang
China

Yujun Tang

Zhejiang Chinese Medical University

Hangzhou, Zhejiang
China

Zhiyu Li

Zhejiang Chinese Medical University

Hangzhou, Zhejiang
China

Yi Zhang

Zhejiang Chinese Medical University

Hangzhou, Zhejiang
China

Jinsong Huang

Zhejiang Chinese Medical University - Xixi Hospital of Hangzhou

Hangzhou, 310023
China

Chengping Wen (Contact Author)

Zhejiang Chinese Medical University ( email )

Hangzhou, Zhejiang
China

Click here to go to TheLancet.com

Paper statistics

Abstract Views
625
Downloads
166